[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
In this study the susceptibility to ciprofloxacin of 100 Pseudomonas aeruginosa strains isolated from various clinical specimens was investigated by disk diffusion test and macrodilution method, and was compared with other various antibiotics. Both of the methods showed that 98 of the strains were susceptible to ciprofloxacin. MIC50 of ciprofloxacin was found to be 0.12, and MIC90 0.50 mcgr/ml for these strains. Pseudomonas aeruginosa strains were found to be highly susceptible to ciprofloxacin in in-vitro conditions.
Sener
B
B
Hacettepe Universitesi, Tip Fakültesi, Mikrobiyoloji Anabilim Dah.
Hayran
M
M
Kocagöz
T
T
Ustaçelebi
S
S
D000583:Amikacin / Q000494:pharmacology; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001398:Aztreonam / Q000494:pharmacology; D002443:Ceftriaxone / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology*; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D015242:Ofloxacin / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002939:Ciprofloxacin; D002443:Ceftriaxone; D000667:Ampicillin; D000583:Amikacin; D015242:Ofloxacin; D001398:Aztreonam
Ciprofloxacinin çeşitli klinik örneklerden izole edilen Pseudomonas aeruginosa suşlarina karşa in-vitro antibakteriyel etkisi ve bu etkinin diğer bazi antibiyotiklerle kiyaslanmasi.